Sponsor or institution
Clinical trials and research at Navy General Hospital, Beijing
As of November 12, 2026, Find a Trial lists 10 clinical trials run by Navy General Hospital, Beijing that are recruiting, in China. By phase: Phase 2 (4), Phase 1/2 (2), Phase 2/3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1Country
Newest trials
All recruiting trials (10)
-
Polatuzumab with zanubrutinib, rituximab, lenalidomide and prednisone as first-line treatment for diffuse large B-cell lymphoma
This trial tests whether adding polatuzumab, zanubrutinib, rituximab, lenalidomide, and prednisone is safe and effective as initial treatment for adults with untreated diffuse large B-cell lymphoma.
-
Using zanubrutinib and lenalidomide for maintenance in lymphoma patients
This study is testing whether the combination of zanubrutinib and lenalidomide can help people with diffuse large B-cell lymphoma stay in remission after chemotherapy.
-
Treatment for elderly patients with higher-risk myelodysplastic syndromes
This study is testing a new treatment combining two medications followed by a stem cell transplant to see if it helps older patients with higher-risk myelodysplastic syndromes live longer and have fewer complications.
-
Smart technology for patient-centered care in pulmonary embolism
A smartphone-based program using wearable tech and AI will help people with pulmonary embolism manage their health and see if it improves long-term outcomes.
-
Combining azacitidine with PD-1 therapy for treating relapsed Hodgkin lymphoma
This study is testing whether combining azacitidine with PD-1 therapy can help people with relapsed Hodgkin lymphoma feel better and live longer.
-
Combining azacytidine with CAOLD for treating relapsed T-cell lymphomas
This study is testing a new combination of azacytidine and CAOLD to see if it helps people with relapsed T-cell lymphomas feel better and live longer.
-
Monitoring blood markers in elderly patients with acute leukemia after chemotherapy
This study is testing if measuring certain blood markers can help doctors understand how well chemotherapy is working for older patients with acute leukemia.
-
Hydrogen treatment for chronic graft-versus-host disease
This study is testing if hydrogen treatment can help people with chronic graft-versus-host disease who haven't responded well to steroid medications.
-
Treatment for elderly patients with primary central nervous system lymphoma
This study is testing a new treatment for older patients with primary central nervous system lymphoma to see if it helps them live longer and feel better without using radiation right away.
-
Treatment for primary central nervous system lymphoma using R-IDARAM and intrathecal chemotherapy
This study tests a new treatment combining R-IDARAM and intrathecal chemotherapy to see if it helps people with primary central nervous system lymphoma feel better and live longer.
Quick answers
How many clinical trials run by Navy General Hospital, Beijing are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 2, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.